NCT Number: NCT05479578
Phase: Phase 1
Trial Summary: This phase I trial tests the safety and side effects of cyclophosphamide given together with dexamethasone in treating patients with castration resistant prostate cancer that has s – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): Rashmi Verma, MD
Acronym:
Cyclophosphamide and Dexamethasone for the Treatment of Metastatic Castration Resistant Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives